Document:

exv10w2

 

Exhibit 10.2

DEARBORN BANCORP, INC.

2005 Long-Term Incentive Plan

RESTRICTED STOCK AWARD AGREEMENT

Grantee:

Number of Restricted Shares Granted:

Grant Date:

     THIS RESTRICTED STOCK AWARD AGREEMENT is effective as of the Grant Date stated above, by and
between Dearborn Bancorp, Inc. and the Grantee.

     WHEREAS, the Restricted Stock described in this Agreement have been granted to the Grantee
pursuant to, and are governed by, the Plan;

     NOW, THEREFORE, the Company and the Grantee hereby agree as follows:

     1. Restricted Stock Grant. Subject to the terms and conditions of this Agreement, the Company
hereby grants to Grantee the number of shares of Restricted Stock as specified above.

     2. Restricted Period. The shares of Restricted Stock are subject to the restrictions contained
in this Agreement and the Plan during the Restricted Period. The restrictions will lapse and the
Restricted Stock will become transferable and non-forfeitable as of the Vesting Date if the Vesting
Criteria set forth in the attached Schedule A — Vesting Criteria Schedule have been met. If the
Vesting Criteria are not met as of the Vesting Date, the Grantee’s rights to the Restricted Stock
will be

 

 

immediately forfeited. The Committee will determine in its sole discretion whether the Vesting
Criteria are met.

     3. Accelerated Vesting. Notwithstanding the satisfaction of the Vesting Criteria referred to
in Section 2 of this Agreement, all shares of Restricted Stock shall become 100% vested upon the
date of a Change in Control.

     4. Delivery of Shares or Cash. Within thirty days after the shares of Restricted Stock have
vested, the Company at the election of the Committee (a) shall deliver to Grantee certificates for
the number of shares of Restricted Stock that have vested pursuant to Sections 2 or (b) pay to the
Grantee in cash the Fair Market Value of such shares as of the date of vesting, or (c) deliver to
the Grantee a combination of stock and cash.

     5. Dividend and Voting Rights. During the Restriction Period, the Grantee shall have the
right to receive dividends in cash or as a stock dividend in respect of such shares of Restricted
Stock and shall have the right to vote such shares as the record owner thereof. Unless otherwise
determined by the Committee, any dividends whether in cash or as a stock dividend payable to the
Grantee during the Restriction Period shall be held by the Company in a special account for the
benefit of the Grantee and be distributed to the Grantee only if and when the applicable Restricted
Shares vest.

2

 

     6. Share Certificates. Each certificate issued for Restricted Shares shall be registered in
the name of the Grantee and deposited with the Company or its designee. At the end of the
Restriction Period, a certificate representing the number of shares which have vested and to which
the Grantee is then entitled shall be delivered to the Grantee free and clear of the restrictions.
If the Vesting Criteria are not met at the end of the Restriction Period, the certificates for such
number of Restricted Shares shall be cancelled.

     7. Deferral of Exercise or Delivery of Shares. Notwithstanding any provision in this Agreement
to the contrary, if any law or regulation of any governmental authority having jurisdiction in the
matter requires the Company, the Committee or the Grantee to take any action or refrain from action
in connection with the delivery of Restricted Stock under this Agreement, or to delay such
delivery, then the delivery of such shares shall be deferred until such action has been taken or
such restriction on action has been removed.

     8. Termination for Cause or Without Consent. Notwithstanding anything in this Agreement to
the contrary, if the Company terminates the Grantee’s employment for Cause prior to a Change in
Control, or the Grantee’s employment is terminated voluntarily by the Grantee and without the
consent of the Company, this Agreement shall be terminated and all Restricted Stock granted to the
Grantee under this Agreement shall be cancelled, regardless of whether the Vesting Criteria set
forth on

3

 

Schedule A have been met on or before such termination date, unless and to the extent that the
Committee determines that such forfeiture would violate applicable law.

     9. Misconduct. The Grantee shall forfeit all rights in his or her Restricted Stock granted
under the Plan, and all such outstanding Restricted Stock shall automatically be cancelled and
lapse, if the Committee determines that the Grantee has (i) used for profit or disclosed to
unauthorized persons, confidential information or trade secrets of the Company, (ii) breached any
contract with or violated any fiduciary obligation to the Company, including without limitation, a
violation of any Company code of conduct, (iii) engaged in unlawful trading in the securities of
the Company or of another company based on information gained as a result of the Grantee’s
employment or other relationship with the Company, or (iv) committed a felony or other serious
crime.

     10. Termination and Employment. If the employment of the Grantee is terminated prior to the
Vesting Date otherwise that as provided in Section 3, the Grantee’s rights to all of the Restricted
Stock will be immediately forfeited.

     11. General Provisions. The Grantee acknowledges that he has read, understands and agrees with
all of the provisions in this Agreement and the Plan, including (but not limited to) the following:

     (a) Authority of Committee. The Committee shall have all the authority set forth in the Plan
including, but not limited to, the authority to administer the Agreement and the Plan; and to adopt
or establish such rules, regulations and agreements,

4

 

guidelines, procedures and instruments which are not contrary to the terms of the Plan which
it believes are necessary or advisable for the administration and operation of the Agreement and
the Plan. Any dispute or disagreement which arises under this Agreement or the Plan shall be
resolved by the Committee in its absolute discretion. Any such determination, interpretation,
resolution, or other action by the Committee shall be final, binding and conclusive with respect to
the Grantee and all other persons affected thereby.

     (b) Notices. Any notice which is required or permitted under this Agreement shall be in
writing (unless otherwise specified in the Agreement or in a writing from the Company to the
Grantee), and delivered personally or by mail, postage prepaid, addressed as follows: (i) if to the
Company, at 1360 Porter Street, Dearborn, Michigan 48124-2823, Attention: Corporate Secretary, or
at such other address as the Company by notice to the Grantee may have designated from time to
time; (ii) if to the Grantee, at the address indicated in the Grantee’s then-current personnel
records, or at such other address as the Grantee by notice to the Company may have designated from
time to time. Such notice shall be deemed given upon receipt.

     (c) Taxation. The Grantee shall be responsible for all applicable income and withholding taxes
and the employee share of FICA taxes with respect to any compensation income generated with respect
to his or her vested Restricted Stock under this Agreement. The Company may reduce the number of
shares of Restricted Stock to pay the applicable FICA withholding taxes on the vested Restricted
Stock and any federal and state income tax withholdings related to such FICA amount.

5

 

     (d) Nontransferability. This Agreement and the Restricted Stock granted to the Grantee shall
be nontransferable and shall not be sold, assigned, transferred or otherwise disposed of, or
mortgaged, pledged or otherwise encumbered by the Grantee to any other person, except as
specifically permitted in this Agreement. No assignment or transfer of this Agreement or the rights
represented thereby, whether voluntary or involuntary, or by operation of law or otherwise, shall
vest in the assignee or transferee any interest or right whatsoever, except as specifically
permitted in this Agreement. The Agreement shall terminate, and be of no force or effect,
immediately upon any attempt to assign or transfer the Agreement or any of the Restricted Stock to
which the Agreement applies.

     (e) Not an Employment Contract. This Agreement shall not be deemed to limit or restrict the
right of the Company to terminate the Grantee’s employment at any time, for any reason, with or
without cause, or to limit or restrict the right of the Grantee to terminate his employment with
the Company at any time.

     (f) Amendment or Termination. This Agreement may be amended or terminated at any time by the
mutual agreement and written consent of the Grantee and the Committee, but only to the extent
permitted under the Plan. The Committee shall have the right to amend the Vesting Criteria set
forth on Schedule A to the Agreement prior to any shares of Restricted Stock becoming vested.

     (g) Governing Instrument. This Agreement is subject to all terms and conditions of the Plan
and shall at all times be interpreted in a manner that is consistent with the intent, purposes, and
specific language of the Plan.

6

 

     (h) Severability. If any provision of this Agreement should be held illegal or invalid for any
reason by the Committee or court of applicable jurisdiction, such determination shall not affect
the other provisions of this Agreement, and it shall be construed as if such provision had never
been included herein.

     (i) Headings/Gender. Headings in this Agreement are for convenience only and shall not be
construed to be part of this Agreement. Any reference to the masculine, feminine or neuter gender
shall be a reference to other genders as appropriate.

     (j) Governing Law. This Agreement shall be construed, and its provisions enforced and
administered, in accordance with the laws of the State of Michigan and, where applicable, federal
law.

     12. Definitions. All capitalized terms shall have the meaning set forth in the Plan or, if not
defined in the Plan, shall be defined as set forth below.

     (a) Cause means (a) willful and continued failure by Grantee substantially to perform
Grantee’s duties and obligations to the Company (other than any such failure resulting from
Grantee’s Disability), (b) the willful engaging by Grantee in misconduct which is materially
injurious to the Company, monetarily or otherwise, or (c) a conviction for or plea of novo
contendere to a felony under the laws of any state within the United States or of the United
States.

     (b) Change in Control has the meaning specified in Section 8 of the Plan.

     (c) Company means Dearborn Bancorp, Inc. and its subsidiaries.

     (d) Grant means the number of shares of Restricted Stock specified on the first page of this
Agreement.

7

 

     (e) Grant Date means the date set forth on the first page of this Agreement.

     (f) Grantee means the person named on the first page of this Agreement.

     (g) Plan means the Dearborn Bancorp, Inc. 2005 Long-Term Incentive Plan, as adopted by the
Board of Directors on April 12, 2005, and approved by the Company’s shareholders on May 17, 2005,
and as amended from time to time.

     (h) Restriction Period means, with respect to Restricted Shares, the period during which any
restrictions set by the Committee remain in place. Restrictions remain in place until such time as
the shares have vested or they have lapsed under the terms and conditions of this Agreement and the
Plan.

     (i) Restricted Stock means the shares of stock, which is granted under the terms and
conditions of this Agreement.

     (j) Vesting
Criteria means the criteria set forth in Schedule A — the Vesting Criteria
Schedule to this Agreement.

     (k) Vesting Date means the date(s) specified in Schedule A — the Vesting Criteria Schedule to
this Agreement by which the Vesting Criteria must be met.

     By accepting the grant of Restricted Stock, the Grantee acknowledges and agrees (i) that the
grant will be exclusively governed by the terms of the Plan, including the right reserved by the
Company to amend or cancel the Plan at any time without the Company incurring liability to the
Grantee (except for grants already awarded under the Plan), (ii) that grants of Restricted Stock
are not a constituent part of salary and that the Grantee is not entitled, under the terms and
conditions of employment, or by accepting or being granted an award under the Plan to require
grants to be awarded to him or her

8

 

in the future under the Plan or any other plan, and (ii) that the Grantee will seek all
necessary approval under, make all required notifications under and comply with all laws, rules and
regulations applicable to the ownership of the Restricted Stock.

     IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly
authorized officers, and the Grantee has executed this Agreement, as of the Grant Date first above
written.

	 	 	 	 	 
	 	 	DEARBORN BANCORP, INC.
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	GRANTEE
	 
	 	 	 	 
	 	 	 
	 	 	Name:
	 

	 	 	 	 

9

 

SCHEDULE A

Vesting Criteria Schedule

10exv4w1

 

Exhibit 4.1

WARRANT

THE WARRANT EVIDENCED OR CONSTITUTED HEREBY, AND ALL SHARES OF COMMON STOCK DELIVERABLE UPON
EXERCISE HEREUNDER, HAVE BEEN AND WILL BE ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF
1933, AS AMENDED (“THE ACT”) AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR
HYPOTHECATED WITHOUT REGISTRATION UNDER THE ACT UNLESS EITHER (A) THE COMPANY HAS RECEIVED AN
OPINION OF COUNSEL, IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT
THAT REGISTRATION IS NOT REQUIRED IN CONNECTION WITH SUCH DISPOSITION OR (B) THE SALE OF SUCH
SECURITIES IS MADE PURSUANT TO SECURITIES AND EXCHANGE COMMISSION RULE 144.

Date: November 29, 2005

WARRANT TO PURCHASE COMMON STOCK

OF

MICROMED CARDIOVASCULAR, INC.

(Subject to Adjustment)

     THIS CERTIFIES THAT, for value received, ___ (“Holder”), is entitled,
subject to the terms and conditions of this Warrant, at any time or from time to time after the
date hereof (the “Effective Date”), to purchase up to ___ (___) shares
of common stock, par value $0.001 per share (the “Warrant Shares”), from MicroMed Cardiovascular,
Inc., a Delaware corporation (the “Company”), at an exercise price per share equal to
Seventy Five Cents ($0.75) (the “Purchase Price). This Warrant shall expire at 5:00 p.m. Pacific
time on that date which is seventy-two (72) months from the date of this Warrant (the
“Expiration Date”). Both the number of shares of Common Stock purchasable upon exercise of
this Warrant (the “Warrant Shares”) and the Purchase Price are subject to adjustment and change as
provided herein. This Warrant is issued in connection with that certain Securities Purchase
Agreement executed by and among the Company, Holder and other parties.

     1. CERTAIN DEFINITIONS. As used in this Warrant the following terms shall have the
following respective meanings:

     “1933 Act” shall mean the Securities Act of 1933, as amended.

     “Common Stock” shall mean the Common Stock of the Company and any other securities at
any time receivable or issuable upon exercise of this Warrant.

     “Fair Market Value” or “FMV” of a share of Common Stock as of a particular
date shall mean:

1

 

               (a) If traded on a securities exchange, the Nasdaq National Market or the Nasdaq Small Cap
Market, the Fair Market Value shall be deemed to be the average of the closing prices of the Common
Stock of the Company on such exchange or market over the five (5) business days ending immediately
prior to the applicable date of valuation;

               (b) If actively traded over-the-counter, the Fair Market Value shall be deemed to be the
average of the closing bid prices over the 30-day period ending immediately prior to the applicable
date of valuation; and

               (c) If there is no active public market, the Fair Market Value shall be the value as
determined in good faith by the Company’s Board of Directors upon a review of relevant factors,
including due consideration of the Registered Holders’ determination of the value of the Company.

     “SEC” shall mean the Securities and Exchange Commission.

     2. EXERCISE OF WARRANT

               2.1 Payment. Subject to compliance with the terms and conditions of this Warrant and
applicable securities laws, this Warrant may be exercised, in whole or in part at any time or from
time to time, on or before the Expiration Date by the delivery (including, without limitation,
delivery by facsimile) of the form of Notice of Exercise attached hereto as Exhibit 1 (the
“Notice of Exercise”), duly executed by the Holder, at the address of the Company as set
forth herein, and as soon as practicable after such date,

                    (a) surrendering this Warrant at the address of the Company, and either

                    (b) providing payment, by check or by wire transfer, of an amount equal to the product
obtained by multiplying the number of shares of Common Stock being purchased upon such exercise by
the then effective Purchase Price (the “Exercise Amount”),

                    (c) by electing, by written notice to the Company on the Notice of Exercise duly executed by
the Holder, to receive a number of Warrant Shares, determined in accordance with the formula set
forth below (the “Election”), in which event the Company shall issue to the Holder a number of
Warrant Shares computed using the following formula:

X= Y(A-B)

A

Where X = The number of Warrant Shares to be issued to the Holder upon an Election.

	 	 	 	 	 	 	 
	 	 	Y
	 	=
	 	The number of Warrant Shares in respect of which this Warrant is being exercised as adjusted to the date of the Election.

	 
	 	 	 	 	 	 

	 	 	A
	 	=
	 	The FMV of one Warrant Share on the date that the relevant Notice of Exercise is received by the Company.

2

 

	 	 	 	 	 	 	 
	 	 	B
	 	=
	 	The Purchase Price (as adjusted to the date of the Election) in accordance with Section 4 hereof

               2.2 Common Stock Certificates; Fractional Shares. As soon as practicable on or after
the date of an exercise of this Warrant, the Company shall deliver to the person or persons
entitled to receive the same a certificate or certificates for the number of whole shares of Common
Stock issuable upon such exercise. No fractional shares or scrip representing fractional shares of
Common Stock shall be issued upon an exercise of this Warrant.

               2.3 Partial Exercise: Effective Date of Exercise. In case of any partial exercise of
this Warrant, the Holder and the Company shall cancel this Warrant upon surrender hereof and shall
execute and deliver a new Warrant of like tenor and date for the balance of the shares of Common
Stock purchasable hereunder. This Warrant shall be deemed to have been exercised immediately prior
to the close of business on the date of its surrender for exercise as provided above. The Company
acknowledges that the person entitled to receive the shares of Common Stock issuable upon exercise
of this Warrant shall be treated for all purposes as the holder of record of such shares as of the
close of business on the date the Holder is deemed to have exercised this Warrant.

     3. TAXES. The Company shall pay all taxes and other governmental charges that may be
imposed in respect of the delivery of shares upon exercise of this Warrant; provided,
however, that the Company shall not be required to pay any tax or other charge imposed in
connection with any transfer involved in the delivery of any certificate for shares of Common Stock
in any name other than that of the Holder of this Warrant, and in such case the Company shall not
be required to deliver any stock certificate until such tax or other charge has been paid, or it
has been established to the Company’s reasonable satisfaction that no tax or other charge is due.

     4. ADJUSTMENT OF PURCHASE PRICE AND NUMBER OF COMMON STOCK. The number of shares of
Common Stock deliverable upon exercise of this Warrant (or any shares of stock or other securities
or property receivable upon exercise of this Warrant) and the Purchase Price are subject to
adjustment upon occurrence of the following events:

               4.1 Adjustment for Stock Splits. Stock Subdivisions or Combinations of Shares of
Common Stock. The Purchase Price of this Warrant shall be proportionally decreased and the number
of shares of Common Stock deliverable upon exercise of this Warrant (or any shares of stock or
other securities at the time deliverable upon exercise of this Warrant) shall be proportionally
increased to reflect any stock split or subdivision of the Company’s Common Stock. The Purchase
Price of this Warrant shall be proportionally increased and the number of shares of Common Stock
deliverable upon exercise of this Warrant (or any shares of stock or other securities at the time
deliverable upon exercise of this Warrant) shall be proportionally decreased to reflect any
combination of the Company’s Common Stock.

               4.2 Adjustment for Dividends or Distributions of Stock or Other Securities or
Property. In case the Company shall make or issue, or shall fix a record date for the
determination of eligible holders entitled to receive, a dividend or other distribution with
respect to the Common Stock (or any shares of stock or other securities at the time issuable upon

3

 

exercise of the Warrant) payable in (a) securities of the Company or (b) assets (excluding
cash dividends paid or payable solely out of retained earnings), then, in each such case, the
Registered Holder of this Warrant on exercise hereof at any time after the consummation, effective
date or record date of such dividend or other distribution, shall receive, in addition to the
shares of Common Stock (or such other stock or securities) issuable on such exercise prior to such
date, and without the payment of additional consideration therefor, the securities or such other
assets of the Company to which such Holder would have been entitled upon such date if such Holder
had exercised this Warrant on the date hereof and had thereafter, during the period from the date
hereof to and including the date of such exercise, retained such shares and/or all other additional
stock available by it as aforesaid during such period giving effect to all adjustments called for
by this Section 4.

               4.3 Reclassification. If the Company, by reclassification of securities or otherwise,
shall change any of the securities as to which purchase rights under this Warrant exist into the
same or a different number of securities of any other class or classes, this Warrant shall
thereafter represent the right to acquire such number and kind of securities as would have been
issuable as the result of such change ‘with respect to the securities that were subject to the
purchase rights under this Warrant immediately prior to such reclassification or other change and
the Purchase Price therefore shall be appropriately adjusted, all subject to further adjustment as
provided in this Section 4. No adjustment shall be made pursuant to this Section 4.3 upon any
conversion or redemption of the Common Stock which is the subject of Section 4.5.

               4.4 Adjustment for Capital Reorganization. Merger or Consolidation. In case of any
capital reorganization of the capital stock of the Company (other than a combination,
reclassification, exchange or subdivision of shares otherwise provided for herein), or any merger
or consolidation of the Company with or into another corporation, or the sale of all or
substantially all the assets of the Company then, and in each such case, as a part of such
reorganization, merger, consolidation, sale or transfer, lawful provision shall be made so that the
Holder of this Warrant shall thereafter be entitled to receive upon exercise of this Warrant,
during the period specified herein and upon payment of the Purchase Price then in effect, the
number of shares of stock or other securities or property of the successor corporation resulting
from such reorganization, merger, consolidation, sale or transfer that a holder of the shares
deliverable upon exercise of this Warrant would have been entitled to receive in such
reorganization, consolidation, merger, sale or transfer if this Warrant had been exercised
immediately before such reorganization, merger, consolidation, sale or transfer, all subject to
further adjustment as provided in this Section 4. The foregoing provisions of this Section 4.4
shall similarly apply to successive reorganizations, consolidations, mergers, sales and transfers
and to the stock or securities of any other corporation that are at the time receivable upon the
exercise of this Warrant. If the per-share consideration payable to the Holder hereof for shares
in connection with any such transaction is in a form other than cash or marketable securities, then
the value of such consideration shall be determined in good faith by the Company’s Board of
Directors. In all events, appropriate adjustment (as determined in good faith by the Company’s
Board of Directors) shall be made in the application of the provisions of this Warrant with respect
to the rights and interests of the Holder after the transaction, to the end that the provisions of
this Warrant shall be applicable after that event, as near as reasonably may be, in relation to any
shares or other property deliverable after that event upon exercise of this Warrant.

4

 

               4.5 Conversion of Common Stock. In case all or any portion of the authorized and
outstanding shares of Common Stock of the Company are redeemed or converted or reclassified into
other securities or property pursuant to the Company’s Certificate of Incorporation or otherwise,
or the Common Stock otherwise ceases to exist, then, in such case, the Registered Holder of this
Warrant, upon exercise hereof at any time after the date on which the Common Stock is so redeemed
or converted, reclassified or ceases to exist (the “Termination Date”), shall receive, in
lieu of the number of shares of Common Stock that would have been deliverable upon such exercise
immediately prior to the Termination Date, the securities or property that would have been received
if this Warrant had been exercised in full and the Common Stock received thereupon had been
simultaneously converted immediately prior to the Termination Date, all subject to further
adjustment as provided in this Warrant. Additionally, the Purchase Price shall be immediately
adjusted to equal the quotient obtained by dividing (x) the aggregate Purchase Price of the maximum
number of shares of Common Stock for which this Warrant was exercisable immediately prior to the
Termination Date by (y) the number of shares of Common Stock of the Company for which this Warrant
is exercisable immediately after the Termination Date, all subject to further adjustment as
provided herein.

     5. LOSS OR MUTILATION. Upon receipt of evidence reasonably satisfactory the Company
of the ownership of and the loss, theft, destruction or mutilation of this Warrant, and of
indemnity reasonably satisfactory to him, and (in the case of mutilation) upon surrender and
cancellation of this Warrant, the Company will cause to be executed and delivered in lieu thereof a
new Warrant of like tenor as the lost, stolen, destroyed or mutilated Warrant.

     6. REPRESENTATION. The Company hereby covenants that all shares issuable upon
exercise of this Warrant, when delivered upon such exercise, shall be free and clear of all liens,
security interests, charges and other encumbrances or restrictions on sale and free and clear of
all preemptive rights, except encumbrances or restrictions arising under federal or state
securities laws. Further, the Company hereby covenants to reserve such number of authorized but
unissued shares of Common Stock for issuance upon exercise of this Warrant.

     7. TRANSFER. This Warrant may not be transferred by the Holder without the prior
written consent of the Company, which consent may not be unreasonably withheld. In the event of a
transfer to which the Company has previously consented in writing, this Warrant and all rights
hereunder may be transferred by the Holder upon delivery of the form of Assignment attached hereto
as Exhibit 2 (the “Assignment”), duly executed by the Holder, surrender of this Warrant
properly endorsed at the address of the Company and payment of any necessary transfer tax or other
governmental charge imposed upon such transfer. Upon any partial transfer, the Holder and Company
will cause to be issued and delivered to the Holder a new Warrant or Warrants with respect to the
portion of this Warrant not so transferred. Each taker and holder of this Warrant, by taking or
holding the same, consents and agrees that when this Warrant shall have been so endorsed, the
person in possession of this Warrant may be treated by the Company, and all other persons dealing
with this Warrant, as the absolute owner hereof for any purpose and as the person entitled to
exercise the rights represented hereby, any notice to the contrary notwithstanding; provided,
however that until a transfer of this Warrant is duly registered on the books of the Company, the
Company may treat the Holder hereof as the owner for all purposes.

5

 

     8. REGISTRATION. The Company has agreed to register the Warrant Shares pursuant to
the Registration Rights Agreement.

     9. RESTRICTIONS ON TRANSFER. The Holder, by acceptance hereof, agrees that, absent an
effective registration statement filed with the SEC under the 1933 Act, covering the disposition or
sale of this Warrant or the Common Stock issued or issuable upon exercise hereof or the Common
Stock issuable upon conversion thereof, as the case may be, and registration or qualification under
applicable state securities laws, such Holder will not sell, transfer, pledge, or hypothecate any
or all such Warrants or Common Stock, as the case may be, unless either (i) the Company has
received an opinion of counsel, in form and substance reasonably satisfactory to the Company, to
the effect that such registration is not required in connection with such disposition or (ii) the
sale of such securities is made pursuant to SEC Rule 144.

     10. COMPLIANCE WITH SECURITIES LAWS. By acceptance of this Warrant, the Holder hereby
represents, warrants and covenants that he/she/it is an “accredited investor” as that term is
defined under Rule 501 of Regulation D, that any shares of stock purchased upon exercise of this
Warrant or acquired upon conversion thereof shall be acquired for investment only and not with a
view to, or for sale in connection with, any distribution thereof, that the Holder has had such
opportunity as such Holder has deemed adequate to obtain from representatives of the Company such
information as is necessary to permit the Holder to evaluate the merits and risks of its investment
in the Company; that the Holder is able to bear the economic risk of holding such shares as may be
acquired pursuant to the exercise of this Warrant for an indefinite period; that the Holder
understands that the shares of stock acquired pursuant to the exercise of this Warrant or acquired
upon conversion thereof will not be registered under the 1933 Act (unless otherwise required
pursuant to exercise by the Holder of the registration rights, if any, previously granted to the
Holder) and will be “restricted securities” within the meaning of Rule 144 under the 1933 Act and
that the exemption from registration under Rule 144 will not be available for at least one year
from the date of exercise of this Warrant, and even then will not be available unless a public
market then exists for the stock, adequate information concerning the Company is then available to
the public, and other terms and conditions of Rule 144 are complied with; and that all stock
certificates representing shares of stock issued to the Holder upon exercise of this Warrant or
upon conversion of such shares may have affixed thereto a legend substantially in the following
form:

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS
OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON
TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS
PERMITTED UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, PURSUANT
TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY
MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN
INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN
OPINION OF

6

 

COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT
ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY
APPLICABLE STATE SECURITIES LAWS.

     11. NO RIGHTS OR LIABILITIES AS STOCKHOLDERS. This Warrant shall not entitle the
Holder to any voting rights or other rights as a stockholder of the Company. In the absence of
affirmative action by such Holder to purchase Common Stock by exercise of this Warrant, no
provisions of this Warrant, and no enumeration herein of the rights or privileges of the Holder
hereof shall cause such Holder hereof to be a holder of the Company for any purpose.

     12. NOTICES. All notices and other communications required or permitted hereunder
shall be in writing and shall be mailed by registered or certified mail, postage prepaid, return
receipt requested, or by telecopier, or by email or otherwise delivered by hand or by messenger,
addressed or telecopied to the person to whom such notice or communication is being given at its
address set forth after its signature hereto. In order to be effective, a copy of any notice or
communication sent by telecopier or email must be sent by registered or certified mail, postage
prepaid, return receipt requested, or delivered personally to the person to whom such notice or
communication is being at its address set forth after its signature hereto. If notice is provided
by mail, notice shall be deemed to be given five (5) business days after proper deposit with the
United States mail or nationally recognized overnight courier, or immediately upon personally
delivery thereof, to person to whom such notice or communication is being at such address. If
notice is provided by telecopier, notice shall be deemed to be given upon confirmation by the
telecopier machine of the receipt of such notice at the telecopier number provided above. If
notice is provided by email, notice shall be deemed to be given upon confirmation by the sender’s
email program of the receipt of such notice at the email address provided after the signature of
the person to whom such notice or communication is being. The addresses set forth after the
signatures hereto may be changed by written notice complying with the terms of this Section 12.

     13. HEADINGS. The headings in this Warrant are for purposes of convenience in
reference only, and shall not be deemed to constitute a part hereof.

     14. LAW GOVERNING. This Warrant shall be construed and enforced in accordance with,
and governed by, the laws of the State of Delaware.

     15. NOTICES OF RECORD DATE. In case:

               15.1 the Company shall take a record of the holders of its Common Stock (or other stock or
securities at the time receivable upon the exercise of this Warrant), for the purpose of entitling
them to receive any dividend or other distribution, or any right to subscribe for or purchase any
shares of stock of any class or any other securities or to receive any other right; or

               15.2 of any consolidation or merger of the Company with or into another corporation, any
capital reorganization of the Company, any reclassification of the capital stock of the Company, or
any conveyance of all or substantially all of the assets of the Company to

7

 

another corporation in which holders of the Company’s stock are to receive stock, securities
or property of another corporation; or

               15.3 of any voluntary dissolution, liquidation or winding-up of the Company; or

               15.4 of any redemption of any outstanding capital stock of the Company; then, and in each such
case, the Company will mail or cause to be mailed to the Holder of this Warrant a notice
specifying, as the case may be, (i) the date on which a record is to be taken for the purpose of
such dividend, distribution or right, or (ii) the date on which such reorganization,
reclassification, consolidation, merger, conveyance, dissolution, liquidation, winding-up,
redemption or conversion is to take place, and the time, if any is to be fixed, as of which the
holders of record of Common Stock (or such stock or securities as at the time are receivable upon
the exercise of this Warrant) shall be entitled to exchange their shares of Common Stock (or such
other stock or securities) for securities or other property deliverable upon such reorganization,
reclassification, consolidation, merger, conveyance, dissolution, liquidation or winding-up. Such
notice shall be delivered at least thirty (30) days prior to the date therein specified.

     16. SEVERABILITY. If any term, provision, covenant or restriction of this Warrant is
held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of
the terms, provisions, covenants and restrictions of this Warrant shall remain in full force and
effect and shall in no way be affected, impaired or invalidated.

     17. COUNTERPARTS. For the convenience of the parties, any number of counterparts of
this Warrant may be executed by the parties hereto and each such executed counterpart shall be, and
shall be deemed to be, an original instrument.

     18. SATURDAYS, SUNDAYS AND) HOLIDAYS. If the Expiration Date falls on a Saturday,
Sunday or legal holiday, the Expiration Date shall automatically be extended until 5:00 p.m. on the
next business day.

[SIGNATURE PAGE TO FOLLOW]

8

 

     IN WITNESS WHEREOF, the parties hereto have executed this Warrant as of this 29th day of
November, 2005.

	 	 	 	 	 	 	 
	MICROMED CARDIOVASCULAR, INC.	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	By:

	 	 	 	By:	 	 
	 

	 	 
	 	 	 	 
	Name: Travis E. Baugh	 	Name:	 	 
	 

	 	 	 	 	 	 
	Title: President and Chief Executive Officer	 	Title:	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Address for Notices:	 	Address for Notices:
	 
	 	 	 	 	 	 
	8965 Interchange Drive	 	 	 	 
	 	 	 	 	 
	Houston TX 77054	 	 	 	 
	 	 	 	 	 

SIGNATURE PAGE TO WARRANT

9

 

EXHIBIT 1

NOTICE OF EXERCISE

(To be executed upon exercise of Warrant)

	 	 	 
	____________

	 	WARRANT NO. ______

     The undersigned hereby irrevocably elects to exercise the right of purchase represented by the
within Warrant Certificate for, and to purchase thereunder, securities of MicroMed Cardiovascular,
Inc., as provided for therein, and (check the applicable box):

	 	 	 	 	 
	 	 	 ̈
	 	Tenders herewith payment of the exercise price in full in the form of cash or a
certified or official bank check in same-day funds in the amount of $______ for
______such securities.

	 
	 	 	 	 

	 	 	 ̈
	 	If applicable pursuant to the cashless exercise feature set forth in Section 2.1(c).

     Please issue a certificate or certificates for such securities in the name of, and pay any
cash for any fractional share to (please print name, address and social security number):

	 	 	 	 	 	 	 
	Name:

	 	 	 	 
	 	 
	 

	 	 	 	 	 	 
	 
	Address:
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	Signature:
	 	 	 	 	 	 
	 

	 	 	 	 	 	 

Note: The above signature should correspond exactly with the name on the first page of this
Warrant Certificate or with the name of the assignee appearing in the assignment form below.

If said number of shares shall not be all the shares purchasable under the within Warrant
Certificate, a new Warrant Certificate is to be issued in the name of said undersigned for the
balance remaining of the shares purchasable thereunder rounded up to the next higher whole number
of shares.

10

 

EXHIBIT 2

ASSIGNMENT

	 	 	 
	(To be executed only upon assignment of Warrant Certificate)

	 	WARRANT NO.-___

     For value received, hereby sells, assigns and transfers unto _________ the
within Warrant Certificate, together with all right, title and interest therein, and does hereby
irrevocably constitute and appoint _______________ attorney, to transfer said
Warrant Certificate on the books of the within-named Company with respect to the number of Warrants
set forth below, with full power of substitution in the premises:

	 	 	 
	Name(s) of Assignee(s)	 	Address	 	 	# of Warrants

And if said number of Warrants shall not be all the Warrants represented by the Warrant
Certificate, a new Warrant Certificate is to be issued in the name of said undersigned for the
balance remaining of the Warrants registered by said Warrant Certificate.

Dated:                                         , 200                    

Signature:                                                             

Notice: The signature to the foregoing Assignment must correspond to the name as written upon the
face of this security in every particular, without alteration or any change whatsoever;
signature(s) must be guaranteed by an eligible guarantor institution (banks, stock brokers, savings
and loan associations and credit unions with membership in an approved signature guarantee
medallion program) pursuant to Securities and Exchange Commission Rule l7Ad-15.

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00094-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00094-of-00352.parquet"}]]